Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism
Resident Survival Guide |
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
FDA on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
CDC on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
Blogs on Supraventricular tachycardia AHA recommendations for Management of SVT of Unknown Mechanism |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of SVT of Unknown Mechanism
Class I |
"1.Vagal maneuvers are recommended for acute treatment in patients with regular SVT "(Level of Evidence: B-R) " |
"2.Adenosine is recommended for acute treatment in patients with regular SVT </nowiki>"</nowiki>(Level of Evidence: B-R) " |
"3.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible " (Level of Evidence: B-NR) " |
"4.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated "(Level of Evidence: B-NR) "
|
Class IIa |
"1. Intravenous diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable SVT "(Level of Evidence:B-R) "
|
"2. Intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT "(Level of Evidence: C-LD) " |